Peter M. Udvarhelyi
University of Bristol
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Peter M. Udvarhelyi.
European Journal of Pharmacology | 1993
Sean A. Eaton; David E. Jane; Philip L.St.J. Jones; Richard Porter; Peter C.-K. Pook; David C. Sunter; Peter M. Udvarhelyi; Peter J. Roberts; T.E. Salt; Jeffrey C. Watkins
Two phenylglycine derivates, (S)-4-carboxyphenylglycine and (RS)-alpha-methyl-4-carboxyphenylglycine, competitively antagonised (1S,3R)-1-aminocyclopentane-1,3-dicarboxylate (ACPD)-stimulated phosphoinositide hydrolysis in rat cerebral cortical slices. The same phenylglycine derivatives selectively antagonized ACPD-induced depolarization in neonatal rat spinal motoneurones and rate thalamic neurones relative to depolarization or excitation induced by N-methyl-D-aspartate (NMDA) or alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA). Both phenylglycine derivatives also selectively depressed synaptic excitation in thalamic neurones evoked by noxious thermal stimuli, without affecting the synaptic stimulation of the same cells by non-noxious stimuli.
Neuroscience | 1993
E. F. Birse; S. A. Eaton; David E. Jane; P. L. Saint J. Jones; R. H. P. Porter; Peter C.-K. Pook; David C. Sunter; Peter M. Udvarhelyi; B. Wharton; Peter J. Roberts; T. E. Salt; Jeffrey C. Watkins
The possible roles of G-protein coupled metabotropic glutamate receptors in central nervous function are currently the focus of intensive investigation. The complexity of effects produced by agonists at these receptors probably reflects the activity of a range of sub-types. The metabotropic glutamate receptors first described are linked to phospholipase C, mediating phosphoinositide hydrolysis and release of Ca2+ from intracellular stores. A substance generally considered to be a selective agonist for these receptors is (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (ACPD). This substance not only stimulates phosphoinositide hydrolysis, but also inhibits cyclic AMP formation. A family of metabotropic glutamate receptors, incorporating both phospholipase C- and adenylcyclase-linked sub-types has been cloned. Various effects of metabotropic glutamate receptor agonists on membrane ion fluxes and synaptic events have been reported, including neuronal depolarization and/or excitation, hyperpolarization, inhibition of Ca(2+)-dependent and voltage-gated K+ currents, potentiation of N-methyl-D-aspartate-induced responses, depression of synaptic excitation and either induction or augmentation of long-term potentiation. To clarify the role of metabotropic glutamate receptors in central nervous activity and to aid the characterization of the various receptor types that may be involved, a range of highly selective agonists and antagonists is required. To date, currently available antagonists such as L-2-amino-3-phosphonopropionate and L-aspartic acid-beta-hydroxamate appear to be unselective and insufficiently potent. We report here the actions of three phenylglycine derivatives, the particular agonist and/or antagonist properties of which may help to elucidate the roles of metabotropic glutamate receptors in central nervous activity.(ABSTRACT TRUNCATED AT 250 WORDS)
European Journal of Pharmacology | 1994
Martyn Kemp; Peter J. Roberts; Peter C.-K. Pook; David E. Jane; Arwel W. Jones; Philip G. Jones; David C. Sunter; Peter M. Udvarhelyi; Jeffrey C. Watkins
The depression of monosynaptic excitation of neonatal rat motoneurones by (1S,3S)- and (1S,3R)-1-aminocyclopentane-1,3-dicarboxylate (ACPD) and by L-2-amino-4-phosphonobutyrate (L-AP4), which is probably presynaptically mediated, is antagonized by (+/-)- and (+)-alpha-methyl-4-carboxyphenylglycine (MCPG). The same phenylglycine derivatives also antagonize the depression of forskolin-stimulated cyclic AMP synthesis effected by the two ACPD stereoisomers and by L-AP4. These results support previous suggestions that presynaptic depression is mediated by metabotropic glutamate receptors negatively coupled to adenylyl cyclase activity. MCPG is the first antagonist to be reported for these receptors.
European Journal of Neuroscience | 1993
S.A. Eaton; E. F. Birse; B. Wharton; David C. Sunter; Peter M. Udvarhelyi; Jeffrey C. Watkins; T.E. Salt
The existence of the so‐called metabotropic excitatory amino acid receptor has been known for some years. Various functions have been suggested for this receptor, but the lack of selective antagonists for (IS, 3R)‐aminocyclopentane dicarboxylic acid (ACPD) has precluded the direct demonstration of a functional role for this receptor in synaptic processes. We describe here a specific antagonism of the excitatory responses of thalamic neurons to ACPD by two novel antagonists, and a parallel antagonism by these compounds of sensory synaptic responses to noxious stimuli of the same neurons. This provides the first direct pharmacological evidence for a functional role of ACPD‐sensitive receptors in central neurotransmission, and indicates that these receptors may play an important part in central sensory processes.
Neuropharmacology | 1993
Steven R. Glaum; David C. Sunter; Peter M. Udvarhelyi; Jeffrey C. Watkins; Richard J. Miller
The effects of the metabotropic glutamate receptor (mGluR) agonist (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid [(1S,3R)-ACPD] and a series of phenylglycine-derived putative mGluR antagonists were examined on electrophysiological responses mediated by glutamate and GABA receptors in the nucleus of the tractus solitarius (NTS) in transverse brainstem slices of the rat. Monosynaptic excitatory currents (EPSCs) evoked by electrical stimulation in the region of the tractus solitarius (TS) were reduced in the presence of (1S,3R)-ACPD in > 90% of neurons recorded in the dorsomedial subdivision of the NTS adjacent to the area postrema (AP). Monosynaptic evoked inhibitory currents (IPSCs) were similarly inhibited by (1S,3R)-ACPD. The inward current evoked by pressure application of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (IAMPA) was potentiated in the presence of (1S,3R)-ACPD, whereas the outward current evoked by the gamma-amino-butyric acid-A (GABA-A) receptor agonist muscimol (IMUSC) was inhibited. (1S,3R)-APCD also produced a postsynaptic inward current (IK(ACPD)) associated with a decrease in membrane conductance in approximately 50% of cells. The novel mGluR antagonists (S)-4-carboxy-3-hydroxy-phenylglycine (4C3H-PG), (R,S)-4-carboxy-phenylglycine (4C-PG) and (R,S)-alpha-methyl-4-carboxy-phenylglycine (alpha M4C-PG) reversibly antagonized the effects of (1S,3R)-ACPD on EPSCs IPSCs, IAMPA and IMUSC. The first two compounds also displayed weak agonist activity. However, none of the antagonists significantly inhibited IK(ACPD) at concentrations which blocked (1S,3R)-ACPD effects on synaptic transmission. These results suggest that pharmacologically distinct mGluRs may be present in the NTS.
Journal of Chromatography A | 1990
Peter M. Udvarhelyi; David C. Sunter; Jeffrey C. Watkins
The resolution of a series of 2-amino-omega-phosphonoalkanoic acid enantiomers using a crown ether chiral stationary phase is described. The method is applicable to other primary amino acid and shows some advantages over chiral derivatization with fluorometric detection. Optical isomers of under 0.5% may be quantified.
Neuropharmacology | 1995
D.J. Chalmers; David E. Jane; David C. Sunter; G.A. Thompson; Peter M. Udvarhelyi; I.C. Kilpatrick; Jeffrey C. Watkins
The four recently synthesized stereoisomers of 3-(4-chlorophenyl) glutamic acid (chlorpheg) were individually examined for their abilities to potentiate depolarizations of neonatal rat motoneurones evoked by L-homocysteic acid (L-HCA, 10 microM). This property had previously been observed using the racemate and is believed to be mediated by uptake inhibition. Both the (2S,3S)- and (2S,3R)- isomers were selective potentiators of L-HCA- (vs L-Glu) induced depolarizations although the (2S,3S)- isomer was more effective. The (2R,3S)- isomer had a slight but significant depressant action which could be attributed to N-methyl-D-aspartate (NMDA) receptor antagonism. Comparison of the potentiating properties of (2S,3S)- and (2S,3R)-chlorpheg with those of L-trans-pyrrolidine-2,4-dicarboxylic acid (tPDC, a L-Glu uptake inhibitor) upon L-HCA- and L-Glu-evoked responses revealed that both chlorpheg isomers (500 microM each) selectively potentiated responses evoked by L-HCA (10 microM) but had no significant effect upon those evoked by L-Glu (50 microM). On the other hand, use of tPDC at the same concentration significantly enhanced the depolarizations evoked by both amino acids, although its action on L-Glu-evoked responses was greater. It is concluded that (i) the (2S,3S)- isomer and to a lesser extent, the (2S,3R)- isomer of chlorpheg are responsible for the potentiating actions seen with the chlorpheg racemate used in previous studies and (ii) (2R,3S)-chlorpheg is a weak NMDA antagonist. The apparently selective action of (2S,3S)- and (2S,3R)-chlorpheg upon L-HCA-relative to L-Glu-induced depolarizations supports the existence of multiple excitatory amino acid uptake sites, some of which may yet be unidentified.
Archive | 1991
Peter M. Udvarhelyi; David C. Sunter; Jeffrey C. Watkins
The resolution of β-(p-chlorophenyl) glutamic acid and β-phenylglutamic acid into two pairs of enantiomers was accomplished by chiral ligand exchange chromatography (LEC). The configurations of the four separated stereoisomers of β-(p-chlorophenyl) glutamic acid at the α-centre were determined by chiroptical spectroscopy. From these measurements it was also possible to establish which of the stereoisomers were enantiomers.
Chirality | 1990
Peter M. Udvarhelyi; Jeffrey C. Watkins
Journal of Medicinal Chemistry | 1996
David E. Jane; David J. Chalmers; Judith A. K. Howard; Ian C. Kilpatrick; David C. Sunter; Gareth A. Thompson; Peter M. Udvarhelyi; Claire Wilson; Jeffrey C. Watkins